Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigation
Open Access

Preclinical Characterization of DPI-4452: A 68Ga/177Lu Theranostic Ligand for Carbonic Anhydrase IX

Frédéric Massière, Norbert Wiedemann, Inês Borrego, Aileen Hoehne, Frank Osterkamp, Matthias Paschke, Dirk Zboralski, Anne Schumann, Anne Bredenbeck, Franck Brichory and Antoine Attinger
Journal of Nuclear Medicine May 2024, 65 (5) 761-767; DOI: https://doi.org/10.2967/jnumed.123.266309
Frédéric Massière
1Debiopharm International SA, Lausanne, Switzerland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norbert Wiedemann
1Debiopharm International SA, Lausanne, Switzerland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Inês Borrego
1Debiopharm International SA, Lausanne, Switzerland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aileen Hoehne
23B Pharmaceuticals GmbH, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Osterkamp
23B Pharmaceuticals GmbH, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Paschke
23B Pharmaceuticals GmbH, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dirk Zboralski
23B Pharmaceuticals GmbH, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Schumann
23B Pharmaceuticals GmbH, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Bredenbeck
23B Pharmaceuticals GmbH, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Franck Brichory
1Debiopharm International SA, Lausanne, Switzerland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antoine Attinger
1Debiopharm International SA, Lausanne, Switzerland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 65 no. 5 761-767
DOI 
https://doi.org/10.2967/jnumed.123.266309
PubMed 
38514083

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication July 27, 2023
  • Revision received February 13, 2024
  • Published online May 1, 2024.

Article Versions

  • previous version (March 21, 2024 - 08:39).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2024 by the Society of Nuclear Medicine and Molecular Imaging. Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: http://jnm.snmjournals.org/site/misc/permission.xhtml.

Author Information

  1. Frédéric Massière*,1,
  2. Norbert Wiedemann*,1,
  3. Inês Borrego1,
  4. Aileen Hoehne2,
  5. Frank Osterkamp2,
  6. Matthias Paschke2,
  7. Dirk Zboralski2,
  8. Anne Schumann2,
  9. Anne Bredenbeck2,
  10. Franck Brichory1 and
  11. Antoine Attinger1
  1. 1Debiopharm International SA, Lausanne, Switzerland; and
  2. 23B Pharmaceuticals GmbH, Berlin, Germany
  1. For correspondence or reprints, contact Antoine Attinger (antoine.attinger{at}debiopharm.com).
  1. ↵* Contributed equally to this work.

View Full Text

Statistics from Altmetric.com

Cited By...

  • 11 Citations
  • 12 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • The Pivotal Role of Preclinical Animal Models in Anti-Cancer Drug Discovery and Personalized Cancer Therapy Strategies
    Haochuan Guo, Xinru Xu, Jiaxi Zhang, Yajing Du, Xinbing Yang, Zhiheng He, Linjie Zhao, Tingming Liang, Li Guo
    Pharmaceuticals 2024 17 8
  • Molecular imaging of renal cell carcinomas: ready for prime time
    Qianyun Wu, Hongda Shao, Wei Zhai, Gang Huang, Jianjun Liu, Jeremie Calais, Weijun Wei
    Nature Reviews Urology 2024
  • Trends in cancer imaging
    Xinyuan Zhou, Binyu Shi, Gang Huang, Jianjun Liu, Weijun Wei
    Trends in Cancer 2024 10 11
  • Biomarkers in advanced renal cell carcinoma: current practice and future directions
    Vivian Wong, Taylor Goodstein, Gabriela Bravo Montenegro, Ramaprasad Srinivasan, Eric A. Singer
    Current Opinion in Oncology 2025 37 3
  • CAIX-targeted PET imaging agents based on acetazolamide small molecule for clear cell renal cell carcinoma
    Chongjiao Li
    American Journal of Nuclear Medicine and Molecular Imaging 2025 15 1
  • Comparison of carbonic anhydrase-IX-targeted trifunctional radioligands between linear- and branched-chain arrangements
    Kazuma Nakashima, Takayoshi Ichinose, Hiroyuki Watanabe, Masahiro Ono
    Frontiers in Nuclear Medicine 2025 5
  • Novel Near Infrared Dyes Targeting Carbonic Anhydrase IX for Fluorescence Imaging Applications
    Roberta Napolitano, Alessia Adamo, Luca Biondi, Alessia Cordaro, Margherita Iaboni, Francesco Stummo, Francesca La Cava, Francesca Arena, Daniele Faletto, Federica Chianale, Erika Reitano, Luisa Poggi, Francesco Blasi
    Investigative Radiology 2025
  • Performance of PSMA-targeted radiotheranostics in an experimental model of renal cell carcinoma
    Rajan Singh, Anand K. Thotakura, Suresh Alati, Alla Lisok, Zirui Jiang, Vanessa F. Merino, Il Minn, Santosh Yadav, Mark C. Markowski, Yasser Ged, Christian P. Pavlovich, Nirmish Singla, Lilja B. Solnes, Michael A. Gorin, Martin G. Pomper, Steven P. Rowe, Sangeeta Ray Banerjee
    Frontiers in Oncology 2024 14
  • Privileged Scaffold Hybridization in the Design of Carbonic Anhydrase Inhibitors
    Daniela Secci, Erica Sanna, Simona Distinto, Alessia Onali, Antonio Lupia, Laura Demuru, Giulia Atzeni, Rita Meleddu, Filippo Cottiglia, Andrea Angeli, Claudiu T. Supuran, Elias Maccioni
    Molecules 2024 29 18
  • Small Organic Carbonic Anhydrase IX Ligands from DNA-Encoded Chemical Libraries for Tumor-Targeted Delivery of Radionuclides
    Marco Müller, Tony Georgiev, Jacqueline Mock, Dario Neri, Samuele Cazzamalli, Sebastian Oehler
    Journal of the American Chemical Society 2025 147 21

Article usage

Article usage: March 2024 to April 2025

AbstractFullPdf
Mar 2024755757270
Apr 2024272505206
May 2024514701288
Jun 2024160322152
Jul 2024145400163
Aug 202475304128
Sep 202452242127
Oct 202457352141
Nov 202465345159
Dec 202434316193
Jan 202544238155
Feb 202528350164
Mar 202534287305
Apr 202540342230
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 65 (5)
Journal of Nuclear Medicine
Vol. 65, Issue 5
May 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preclinical Characterization of DPI-4452: A 68Ga/177Lu Theranostic Ligand for Carbonic Anhydrase IX
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Preclinical Characterization of DPI-4452: A 68Ga/177Lu Theranostic Ligand for Carbonic Anhydrase IX
Frédéric Massière, Norbert Wiedemann, Inês Borrego, Aileen Hoehne, Frank Osterkamp, Matthias Paschke, Dirk Zboralski, Anne Schumann, Anne Bredenbeck, Franck Brichory, Antoine Attinger
Journal of Nuclear Medicine May 2024, 65 (5) 761-767; DOI: 10.2967/jnumed.123.266309

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Preclinical Characterization of DPI-4452: A 68Ga/177Lu Theranostic Ligand for Carbonic Anhydrase IX
Frédéric Massière, Norbert Wiedemann, Inês Borrego, Aileen Hoehne, Frank Osterkamp, Matthias Paschke, Dirk Zboralski, Anne Schumann, Anne Bredenbeck, Franck Brichory, Antoine Attinger
Journal of Nuclear Medicine May 2024, 65 (5) 761-767; DOI: 10.2967/jnumed.123.266309
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENTS
    • Footnotes
    • References
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • In Vivo Visualization and Quantification of Brain Heat Shock Protein 90 with [11C]HSP990 in Healthy Aging and Neurodegeneration
  • 161Tb Radioimmunotherapy as a Treatment for CD30-Positive Lymphomas
  • 212Bi-Macroaggregated Albumin Inhibited Mouse Melanoma Growth by Regulating Cell Cycle Checkpoint Markers Without Promoting Living Cell Repopulation
Show more Basic Science Investigation

Similar Articles

Keywords

  • CAIX
  • 177Lu
  • 68Ga
  • dog
  • mouse
SNMMI

© 2025 SNMMI

Powered by HighWire